MAPT and Alzheimer disease: The deposition of amyloid β (Aβ) peptides as senile plaques and tau as neurofibrillary changes causes the hallmark neuropathological lesions of Alzheimer’s disease (AD), which are implicated in its pathogenesis and deemed as the prime target for disease-modifying therapies (DMTs).